There are 68 papers on left ventricular dysfunction in aging research: 5 trials and 36 observational studies in people, 17 in animals, 8 reviews.
68 papers study it29 more mention it16 findings
14 new papers in 30 daysSee all 97 papers on left ventricular dysfunction
“AI-ECG models showed high accuracy for detecting left ventricular dysfunction (AUC 0.887 for QCG-LVD and 0.896 for ECG-LVGLS)”
- Human trial5
- Humans36
- Animals17
- In silico1
Interventions
3Transcatheter aortic valve implantation
downin humans1
1 study
Transcatheter aortic valve implantation
downin humans1
Transcatheter aortic valve implantation is linked with lower left ventricular dysfunction in humans (severe symptomatic aortic stenosis).
“Left ventricular dysfunction appeared to improve after TAVI, even in nonagenarians.”
Humanssevere symptomatic aortic stenosis
Is Transcatheter Aortic Valve Implantation Still Effective in Nonagenarians?
The Israel Medical Association journal : IMAJ
Renin-angiotensin-aldosterone system inhibitors
no changein humans1HR 1.1
1 study
Renin-angiotensin-aldosterone system inhibitors
no changein humans1HR 1.1
Renin-angiotensin-aldosterone system inhibitors were not clearly linked with left ventricular dysfunction in AI-ECG low-risk group with baseline LVEF ≥ 50% (HR 1.10, 95% CI 0.80–1.52).
“this effect was not observed in the low-risk group (HR, 1.10; 95% CI, 0.80–1.52; p for interaction = 0.028; Figure 1).”
Humansin AI-ECG low-risk group with baseline LVEF ≥ 50%median follow-up of 1,320 days
AHA Scientific Sessions 2025 abstract
Caloric restriction + exercise
downin rats1
1 study
Caloric restriction + exercise
downin rats1
Caloric restriction + exercise decreases left ventricular dysfunction in rats (ovariectomized obese prediabetic rats; compared with exercise or calorie restriction alone).
“The combination of calorie restriction and exercise exerted greater efficacy in attenuating LV dysfunction”
Animalsovariectomized obese prediabetic rats; compared with exercise or calorie restriction alonecombined calorie restriction and exerciseleft ventriclesix weeks of interventionsfemales
Experimental gerontology
Effects
5Oxidative stress and ROS signaling
upin rats1
1 study
Oxidative stress and ROS signaling
upin rats1
Left ventricular dysfunction increases oxidative stress and ROS signaling in rats.
“The number of p16ink4a-positive and 8-hydroxy-2'-deoxyguanosine-positive podocytes was greater in the reduced EF group than in the preserved EF group at both time points.”
Animalspost-myocardial infarction, reduced vs preserved ejection fraction; 8-hydroxy-2'-deoxyguanosine-positive podocyteskidney3 and 9 weeks
Renal failure
Cellular senescence
upin rats1
1 study
Cellular senescence
upin rats1
Left ventricular dysfunction increases cellular senescence in rats.
“The number of p16ink4a-positive and 8-hydroxy-2'-deoxyguanosine-positive podocytes was greater in the reduced EF group than in the preserved EF group at both time points.”
Animalspost-myocardial infarction, reduced vs preserved ejection fraction; p16ink4a-positive podocyteskidney3 and 9 weeks
Renal failure
Podocyte injury
upin rats1
1 study
Podocyte injury
upin rats1
Left ventricular dysfunction increases podocyte injury in rats.
“was more significant in the reduced EF group than in the preserved EF group at 9, but not 3 weeks.”
Animalspost-myocardial infarction, reduced vs preserved ejection fraction; desmin and Wilms' tumor-1 immunostainingglomerulus9 weeks
Renal failure
Renal fibrosis
upin rats1
1 study
Renal fibrosis
upin rats1
Left ventricular dysfunction increases renal fibrosis in rats (post-myocardial infarction, reduced vs preserved ejection fraction).
“Renal fibrosis and inflammatory cell infiltrations increased significantly in the reduced EF group than in the preserved EF group at 3 and 9 weeks.”
Animalspost-myocardial infarction, reduced vs preserved ejection fractionkidney3 and 9 weeks
Renal failure
Early peak diastolic kinetic energy
no changein humans1
1 study
Early peak diastolic kinetic energy
no changein humans1
Left ventricular dysfunction was not clearly linked with early peak diastolic kinetic energy in humans (Compared with older healthy adults).
“compared with older healthy adults exhibited a similar early peak diastolic KE (P = 0.142)”
HumansCompared with older healthy adultsleft ventriclen = 10
Age-related changes in intraventricular kinetic energy: a physiological or pathological adaptation?
American journal of physiology. Heart and circulatory physiology
Upstream
1NNT
downin mice1
1 study
NNT
downin mice1
NNT protects against left ventricular dysfunction in aged Nnt-/- mice.
“moderately reduced ejection fraction and fractional shortening at older ages, suggesting left ventricular dysfunction”
Animalsin aged Nnt-/- miceheart
Redox biology
Associations
6AI-ECG
upin humans2HR 3.68
2 studies
AI-ECG
upin humans2HR 3.68
AI-ECG predicts left ventricular dysfunction in humans (AUC 0.887 for QCG-LVD and 0.896 for ECG-LVGLS).
“AI-ECG models showed high accuracy for detecting left ventricular dysfunction (AUC 0.887 for QCG-LVD and 0.896 for ECG-LVGLS)”
Humans48.2% malesn = 38,804
Scientific reports
AI-ECG predicts left ventricular dysfunction in humans (AI-ECG high-risk group vs low-risk group) (HR 3.68, 95% CI 3.02–4.49).
“Over a median follow-up of 1,320 days, the high-risk group had a significantly greater risk of incident LVEF ≤ 40% (hazard ratio [HR], 3.68; 95% confidence interval [CI]: 3.02–4.49).”
HumansAI-ECG high-risk group vs low-risk groupmedian follow-up of 1,320 daysn = 7,169
AHA Scientific Sessions 2025 abstract
Renin-angiotensin-aldosterone system inhibitors
downin humans1HR 0.7
1 study
Renin-angiotensin-aldosterone system inhibitors
downin humans1HR 0.7
Renin-angiotensin-aldosterone system inhibitors are linked with a lower risk of left ventricular dysfunction in AI-ECG high-risk group with baseline LVEF ≥ 50% (HR 0.70, 95% CI 0.54–0.90).
“In the high-risk group, ACEi or ARB therapy was associated with a lower risk of LVEF decline compared to no treatment (HR, 0.70; 95% CI, 0.54–0.90)”
Humansin AI-ECG high-risk group with baseline LVEF ≥ 50%median follow-up of 1,320 days
AHA Scientific Sessions 2025 abstract
Wake Forest's ECG-AI model
upin humans1
1 study
Wake Forest's ECG-AI model
upin humans1
Wake Forest's ECG-AI model predicts left ventricular dysfunction in humans (AUC 0.91 (95% CI: 0.80–1.00)).
“The model achieved an AUC of 0.91 (95% CI: 0.80–1.00).”
Humans65.5% womensn = 1,276
Population Screening for LV Dysfunction Using Single-Lead ECG-AI: Insights from the RURAL Study
AHA Scientific Sessions 2025 abstract
centenarians
upin humans1
1 study
centenarians
upin humans1
Left ventricular dysfunction is associated with centenarians in humans (population-based sample of persons turning 100 years) (68 (54%)).
“Left ventricular (LV) dysfunction was present in 68 (54%) of the participants of whom less than half had HF symptoms.”
Humanspopulation-based sample of persons turning 100 yearsn = 125
Diagnosing heart failure in centenarians
Journal of geriatric cardiology : JGC
Kinetic energy in diastasis
upin humans1
1 study
Kinetic energy in diastasis
upin humans1
Left ventricular dysfunction is associated with kinetic energy in diastasis in humans (Compared with older healthy adults).
“but with the addition of an elevated KE in diastasis (P = 0.029).”
HumansCompared with older healthy adultsleft ventriclen = 10
Age-related changes in intraventricular kinetic energy: a physiological or pathological adaptation?
American journal of physiology. Heart and circulatory physiology
Ejection fraction
downin humans1
1 study
Ejection fraction
downin humans1
Left ventricular dysfunction is associated with ejection fraction in humans (Patients with left ventricular dysfunction).
“Subjects with LV dysfunction had reduced ejection fraction (P < 0.001)”
HumansPatients with left ventricular dysfunctionleft ventriclen = 10
Age-related changes in intraventricular kinetic energy: a physiological or pathological adaptation?
American journal of physiology. Heart and circulatory physiology
Trial sponsors
Company1 trialPhase 4252 people
Company1 trialPhase 33,080 people
Company1 trialPhase 3730 people
Company1 trialPhase 318 people
Company3 trialsPhase 2242 people
Company1 trial50 people
1 trialPhase 4118 people
The University of Texas at Arlington
1 trialPhase 4100 people
Funding
2 grants since 2018National Heart, Lung, and Blood Institute$3.3MNational Institute on Aging$194K